Fortress Biotech Inc (FBIO)
1.74
-0.02
(-1.14%)
USD |
NASDAQ |
May 15, 15:22
Fortress Biotech Free Cash Flow: -136.32M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -136.32M |
| September 30, 2023 | -129.56M |
| June 30, 2023 | -156.07M |
| March 31, 2023 | -177.48M |
| December 31, 2022 | -182.46M |
| September 30, 2022 | -196.42M |
| June 30, 2022 | -181.37M |
| March 31, 2022 | -158.94M |
| December 31, 2021 | -132.89M |
| September 30, 2021 | -112.74M |
| June 30, 2021 | -110.15M |
| March 31, 2021 | -89.32M |
| December 31, 2020 | -90.85M |
| September 30, 2020 | -98.54M |
| June 30, 2020 | -91.90M |
| March 31, 2020 | -102.40M |
| December 31, 2019 | -104.36M |
| September 30, 2019 | -98.31M |
| June 30, 2019 | -106.19M |
| March 31, 2019 | -105.14M |
| December 31, 2018 | -108.20M |
| September 30, 2018 | -107.42M |
| June 30, 2018 | -105.45M |
| March 31, 2018 | -101.60M |
| December 31, 2017 | -85.32M |
| Date | Value |
|---|---|
| September 30, 2017 | -81.68M |
| June 30, 2017 | -67.03M |
| March 31, 2017 | -54.55M |
| December 31, 2016 | -56.32M |
| September 30, 2016 | -44.82M |
| June 30, 2016 | -40.12M |
| March 31, 2016 | -36.44M |
| December 31, 2015 | -32.36M |
| September 30, 2015 | -28.11M |
| June 30, 2015 | -24.25M |
| March 31, 2015 | -20.34M |
| December 31, 2014 | -16.33M |
| September 30, 2014 | -19.94M |
| June 30, 2014 | -24.36M |
| March 31, 2014 | -28.41M |
| December 31, 2013 | -29.83M |
| September 30, 2013 | -29.81M |
| June 30, 2013 | -27.32M |
| March 31, 2013 | -25.26M |
| December 31, 2012 | -23.19M |
| September 30, 2012 | -19.75M |
| June 30, 2012 | -18.02M |
| March 31, 2012 | -14.63M |
| December 31, 2011 | -14.80M |
Free Cash Flow Range, Past 5 Years
-196.42M
Minimum
Sep 2022
-89.32M
Maximum
Mar 2021
-129.28M
Average
-112.74M
Median
Sep 2021
Free Cash Flow Benchmarks
| Journey Medical Corp | 0.24M |
| Avenue Therapeutics Inc | -12.45M |
| Mustang Bio Inc | -49.59M |
| Checkpoint Therapeutics Inc | -40.03M |
| Viking Therapeutics Inc | -54.87M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.94M |
| Cash from Investing (Quarterly) | -0.063M |
| Cash from Financing (Quarterly) | 43.62M |
| Free Cash Flow Per Share (Quarterly) | -3.252 |
| Free Cash Flow to Equity (Quarterly) | -50.06M |
| Free Cash Flow to Firm (Quarterly) | -33.63M |
| Free Cash Flow Yield | -966.5% |